Precigen (PGEN) Change in Receivables (2012 - 2026)
Precigen (PGEN) posted quarterly Change in Receivables of $22.5 million for Q1 2026, up 12949.71% year-over-year from N/an in Q1 2025, and up 574.07% quarter-over-quarter from $3.3 million in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Change in Receivables (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Change in Receivables for 15 consecutive years, with $22.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 12949.71% year-over-year to $22.5 million; the TTM figure through Mar 2026 stood at $25.7 million (up 21300.0% YoY), while the FY2025 annual figure was $3.0 million, up 12358.33% from the prior year.
- Change in Receivables rose to $22.5 million in Q1 2026 per PGEN's latest filing, from $3.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $22.5 million in Q1 2026 and bottomed at -$4.6 million in Q3 2022.
- Historically, Change in Receivables has averaged $1.6 million across 5 years, with a median of -$32000.0 in 2024.
- Annual changes were most pronounced in 2025 — Change in Receivables plunged 483.33% — and 2026, when it jumped 12949.71%.
- Precigen's Change in Receivables stood at -$271000.0 in 2022, then jumped by 68.27% to -$86000.0 in 2023, then soared by 619.77% to $447000.0 in 2024, then soared by 646.31% to $3.3 million in 2025, then soared by 574.07% to $22.5 million in 2026.
- Business Quant data shows PGEN's Change in Receivables at $22.5 million in Q1 2026, $3.3 million in Q4 2025, and $253000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 45.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.46 Mn |
| Mar 31, 2026 | 22.49 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | -424,000.00 |
| Mar 31, 2025 | -175,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | -32,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -86,000.00 |
| Sep 30, 2023 | -366,000.00 |
| Jun 30, 2023 | -417,000.00 |
| Mar 31, 2023 | 793,000.00 |
| Dec 31, 2022 | -271,000.00 |
| Sep 30, 2022 | -4.57 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 945,000.00 |
| Sep 30, 2021 | -5.30 Mn |